Literature DB >> 2545763

Lack of aldosterone inhibition by atrial natriuretic factor in primary aldosteronism: in vitro studies.

S Rocco1, G Opocher, D D'Agostino, L Leone, F Mantero.   

Abstract

Several studies demonstrated that aldosterone secretion, by bovine, rat and human glomerulosa cells, is inhibited in vitro by atrial natriuretic factor (ANF). This effect has also been investigated with conflicting results in cells taken from aldosterone-producing tumors. In the present study, atrial natriuretic factor has been tested on aldosteronoma cells obtained from 4 patients with primary aldosteronism. The cells were studied both with perfusion and incubation systems. Aldosterone secretion was stimulated by ACTH, angiotensin II and potassium with or without ANF 10 microM. In this study ANF lacked to inhibit either basal and stimulated aldosterone secretion, indicating some alterations of ANF-adrenal interaction in this syndrome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545763     DOI: 10.1007/BF03349905

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  29 in total

Review 1.  The heart and the atrial natriuretic factor.

Authors:  M Cantin; J Genest
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

2.  Lack of inhibitory effect of alpha-human atrial natriuretic polypeptide on aldosteronogenesis in aldosterone-producing adenoma.

Authors:  K Higuchi; H Nawata; K Kato; H Ibayashi; H Matsuo
Journal:  J Clin Endocrinol Metab       Date:  1986-07       Impact factor: 5.958

3.  Atrial natriuretic polypeptide inhibits cortisol secretion as well as aldosterone secretion in vitro from human adrenal tissue.

Authors:  M Naruse; K Obana; K Naruse; H Yamaguchi; H Demura; T Inagami; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1987-01       Impact factor: 5.958

4.  Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers.

Authors:  A M Richards; M G Nicholls; H Ikram; M W Webster; T G Yandle; E A Espiner
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

5.  Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.

Authors:  T Maack; D N Marion; M J Camargo; H D Kleinert; J H Laragh; E D Vaughan; S A Atlas
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

6.  Alpha-human atrial natriuretic polypeptide inhibits steroidogenesis in cultured human adrenal cells.

Authors:  K Higuchi; H Nawata; K Kato; H Ibayashi; H Matsuo
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

Review 7.  Molecular characteristics of receptors for atrial natriuretic factor.

Authors:  R L Vandlen; K E Arcuri; L Hupe; M E Keegan; M A Napier
Journal:  Fed Proc       Date:  1986-08

8.  Effect of verapamil on the aldosterone-stimulating properties of metoclopramide: in vitro and in vivo studies.

Authors:  G Opocher; A Murgia; S Rocco; D D'Agostino; M Boscaro; A Menegus; F Mantero
Journal:  Horm Metab Res       Date:  1986-11       Impact factor: 2.936

9.  Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues.

Authors:  C Bianchi; J Gutkowska; G Thibault; R Garcia; J Genest; M Cantin
Journal:  Histochemistry       Date:  1985

10.  Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension.

Authors:  T Yamaji; M Ishibashi; H Sekihara; F Takaku; H Nakaoka; J Fujii
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

View more
  1 in total

1.  Natriuretic peptides receptors in human aldosterone-secreting adenomas.

Authors:  R Sarzani; G Opocher; M V Paci; A S Belloni; F Mantero; P Dessì-Fulgheri; A Rappelli
Journal:  J Endocrinol Invest       Date:  1999 Jul-Aug       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.